University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Location status: Recruiting
Location contact
Almaris Figueroa-Gonzalez
CONTACT
Camille Blaine
CONTACT
Desmond J Oathes, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT05437705
The research study is being conducted to study brain patterns of negative emotion and develop personalized brain stimulation protocols to disrupt these patterns with transcranial magnetic stimulation (TMS). First, the investigators will use functional Magnetic Resonance Imaging (fMRI) data to generate a negative affect map for each participant. Then, the investigators will apply a variety of repetitive transcranial magnetic stimulation (rTMS) sequences while the participant is inside the MRI scanner to determine the optimal and least optimal rTMS frequencies at changing negative affect brain states. Finally, these two frequencies will be tested over two 3-day rTMS neuromodulation sessions to assess whether they can reduce negative emotions.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
Philadelphia, Pennsylvania, 19104, United States
Location status: Recruiting
Almaris Figueroa-Gonzalez
CONTACT
Camille Blaine
CONTACT
Desmond J Oathes, PhD
PRINCIPAL_INVESTIGATOR
The study involves 11 visits over approximately 10 weeks, depending on scanner availability and scheduling. See below for the study schedule with a summary of the procedures:
After completing all procedures, participants will receive the full study compensation. Payments may be issued earlier if participants request compensation after each visit or if they withdraw early.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
During this study, participants are asked to:
Transcranial Magnetic Stimulation (TMS) is a non-invasive form of brain stimulation. TMS can influence activity in various brain regions, and it allows researchers to test or modify brain circuit communication. The MagPro X100* magnetic stimulator and Cool-B65 Butterfly Coil are FDA-approved for rTMS treatments of depression.
Time frame: Up to 4 weeks
By comparing the RRS score change pre/post rTMS of both neuromodulation sessions (Visits 4-6/7-9) the investigators will determine whether the optimal rTMS stimulation frequency is more effective at improving clinical outcomes.
Contact information is provided by the study sponsor or research team.
Almaris Figueroa-Gonzalez
CONTACT
Camille Blaine
CONTACT
University of Pennsylvania
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07478393
Anxiety, Anxiety Disorders
New York, United States
View Trial DetailsNCT07503093
Anxiety, Anxiety Disorders
Belmont, Massachusetts, United States
View Trial DetailsNCT07627139
Anxiety, Anxiety Disorders
View Trial DetailsNCT06570694
Anxiety, Anxiety Disorders
View Trial Details